United Kingdom· GB-APID-37532311000001105
Rasilez 150mg tablets
A aliskiren product containing aliskiren, registered in United Kingdom by CST Pharma Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Aliskiren is registered in 13 of 19 countries.
Countries holding a registration under ATC C09XA02 (aliskiren), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Aliskiren · ATC C09XA02
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aliskiren costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.95 in Italy to $3.43 in United States — a ×3.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Aliskiren · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- US United States$3.43 (acquisition cost)
- IT Italy$0.95
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Aliskiren
- Manufacturer
- CST Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- C09XA02
- ATC class
- Aliskiren
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5055946801124
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
227 interactions on record for aliskiren.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aliskiren · interactions on record
227 records
- 1 severe
- 147 moderate
- 26 info
Most severe, free to view
- CiclosporinL04AD01severe
- ClotrimazoleA01AB18moderate
- AprepitantA04AD12moderate
- RolapitantA04AD14moderate
53 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aliskiren in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayRasilezNoden Pharma
- SpainRASILEZ 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULANoden Pharma Designated Activity Company
- SwitzerlandRasilez 150 mg, FilmtablettenFuture Health Pharma GmbH
- PolandRasilezNoden Pharma DAC
- SwedenRasilez 150 mg Filmdragerad tablettLXO Ireland DAC
- United StatesALISKIRENEndo USA, Inc.
- IcelandRasilezNoden Pharma DAC
- ItalyRASILEZ*28 cpr rivestite 150 mgNODEN PHARMA DAC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rasilez
- Liechtenstein · Rasilez
- Norway · Rasilez
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5980b983-e9b8-4a8d-98e0-281c5f3faadc GET /v1/drugs/5980b983-e9b8-4a8d-98e0-281c5f3faadc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37532311000001105",
"desc": "Rasilez 150mg tablets (CST Pharma Ltd)",
"form": "Oral tablet",
"vpid": "39731411000001101",
"source": "dmd",
"vtm_id": "774471001",
"strength": "150 mg",
"substance": "Aliskiren",
"ingredient": "Aliskiren hemifumarate",
"supplier_code": "24059811000001102"
}See everything about aliskiren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.